ALTO NEUROSCIENCE, INC.

Leading Innovation in Psychiatric Treatment | Alto Neuroscience

Los Altos, United States · Founded 2020 · $168.2M raised

Employees
1–10
Founded
2020
Business Model
B2B
Total Funding
$168.2M
Last Round
$120.0M Growth EquityMar 2026
Rounds
3

About

Alto Neuroscience is a clinical-stage biopharmaceutical company redefining psychiatry by leveraging deep neurobiological insights to develop personalized medicines for neuropsychiatric conditions. Using a precision psychiatry platform built on 15 years of neurobiology research, the company targets core brain processes in patients with major depressive disorder, bipolar depression, and schizophrenia.

Summary

ALTO NEUROSCIENCE, INC. is a Biotech company based in Los Altos, United States, founded in 2020. It has raised $168.2M in total across 3 rounds, most recently a $120.0M Growth Equity round in Mar 2026.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Growth EquityGrowth EquityMar 2026
$120.0M

Sign up to see all 3 rounds

Grant through Growth Equity — per-round amounts, valuations, and who invested in each round.

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

ALTO NEUROSCIENCE, INC. on Indexed.vc
<a href="https://indexed.vc/companies/alto-neuroscience-inc"><img src="https://indexed.vc/api/badge/company/alto-neuroscience-inc" alt="ALTO NEUROSCIENCE, INC. on Indexed.vc" width="260" height="76" /></a>